This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Menopause and cardiovascular (CV) disease risk

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Menopause and cardiovascular risk

  • CHD is unusual in women before the menopause; the corollary is that the postmenopausal state increases risk significantly. By the time a woman reaches the age of 60, the gap in incidence of CHD between men and women is greatly reduced

    • risk is thought to be due to the withdrawal of the protective effect of oestrogen around the time of the menopause, although this explanation is not universally accepted

    • around menopause, a clustering of obesity, hypertension and dyslipidemia is often seen. Similarly polycystic ovary syndrome is also linked with cardiovascular risk factors and more adverse CHD events post-menopause

    • increased CHD risk has also been observed in pre-menopausal women with irregular or disrupted menstrual cycles and in those with oestrogen deficiency or hypothalamic dysfunction

    • replacement of oestrogen after the menopause has not been shown to be effective in preventing cardiovascular events and HRT is not recommended for cardiac protection in females with CHD after the HERS trial showed no evidence of benefit

Reference:

  • 1) BHF Factfile (November 2010). Women and coronary heart disease.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.